跳至主要内容
临床试验/NCT01193920
NCT01193920已完成1 期

A Phase Ib/II Randomized, Observer-Blind, Controlled, Single Centre Study of a Trivalent Group B Streptococcus Vaccine in Healthy Non-Pregnant Women Leading Into a Dose-Ranging Study in Pregnant Women in South Africa

Novartis Vaccines1 个研究点 分布在 1 个国家目标入组 380 人开始时间: 2010年10月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
380
试验地点
1
主要终点
The Percentages of Maternal Subjects With Antibody Concentrations Above a Defined Threshold at Day of Delivery.

研究概览

简要总结

This study will evaluate the safety and immunogenicity of a Group B Streptococcus vaccine at one dose in healthy non pregnant women and then in three different doses in healthy pregnant women.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Group 1 (Non Pregnant Women): Healthy females 18-40 years of age inclusive.
  • Group 2 (Healthy Pregnant Women): Healthy pregnant women 18-40 yrs of age (between 28-35 weeks gestation)

排除标准

  • Group 1 (Non Pregnant Women): Pregnant or nursing; History of severe allergy to previous vaccines; Known HIV positive
  • Group 2 (Healthy Pregnant Women): History of severe allergy to previous vaccines; Known HIV positive

结局指标

主要结局

The Percentages of Maternal Subjects With Antibody Concentrations Above a Defined Threshold at Day of Delivery.

时间窗: Day of delivery

The percentages of maternal subjects with antibody concentrations above a defined threshold per serotype following the administration of one of three different doses of the study vaccine or placebo.Antibody concentrations which exceed pre-defined serotype specific ELISA values are 1, 2, 3, 5 and 8 μg/mL.

The Percentages of Non-pregnant Subjects With Antibody Concentrations Above a Defined Threshold at One Month After the Second Vaccination.

时间窗: Day 61, one month after the second vaccination

The percentages of non-pregnant subjects with antibody concentrations above a defined threshold per serotype after the administration of two vaccine doses administered one month apart. Defined thresholds for antibody concentrations, which exceed pre-defined serotype specific ELISA values are 1, 2, 3, 5 and 8 μg/mL.

Antibody Geometric Mean Concentrations (GMC) in Non-pregnant Women at One Month After the Second Vaccination.

时间窗: Day 61, one month after the second vaccination

Antibody GMC per serotype in non-pregnant women after receiving two doses of the study vaccine administered one month apart .

Antibody GMC in Maternal Subjects at Day of Delivery

时间窗: Day of delivery

Antibody GMC per serotype in maternal subjects at day of delivery following one administration of one of three different doses of the study vaccine or placebo are reported.

次要结局

  • The Percentage of Non-pregnant Subjects With Antibody Concentrations Above a Defined Threshold at One Year After the First Vaccination.(Day 361, one year after the first vaccination)
  • Antibody GMC in Non-pregnant Subjects at One Year After the First Vaccination(Day 361, one year after the first vaccination)
  • The Percentages of Maternal Subjects With Antibody Concentrations Above a Defined Threshold Per Serotype at One Month After Vaccination.(Day 31, one month after vaccination)
  • Number of Non-pregnant Subjects Reporting Solicited and Unsolicited Adverse Events(Day 61)
  • Number of Maternal Subjects Reporting Solicited and Unsolicited Adverse Events(From day 1 to one year after delivery)
  • Antibody GMC Per Serotype in Maternal Subjects at One Month After Vaccination(day 31)
  • Antibody GMC Per Serotype at Different Time Points in Infants(Day 4, day 43 and day 91 after birth)
  • Number of Infants Reporting Serious Adverse Events(one year after birth)

研究者

发起方
Novartis Vaccines
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验